Detailed text transcripts for TV channel - MSNBC - 20150923:07:49:00
Late breaking news tonight with the ceo of turing pharmaceuticals 32-year-old former hedge fund manager martin shkreli announcing he is reversing course after coming under tremendous criticism for raising the price of a drug 5000%. the drug daraprim is used to treat toxoplasmosis. after buying rights to the 62-year-old drug last month, turing pharmaceuticals raised the price from $13.50 per pill up to $750 a pill taking the total treatment cost from around $1,000 up to $63,000. daraprim costs very little to make. the price increase prompted protests and outrage online. martin shkreli was defia...